Details for New Drug Application (NDA): 062751
✉ Email this page to a colleague
The generic ingredient in C-SOLVE-2 is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 062751
Tradename: | C-SOLVE-2 |
Applicant: | Ivax Sub Teva Pharms |
Ingredient: | erythromycin |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 062751
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SWAB;TOPICAL | Strength | 2% | ||||
Approval Date: | Jul 30, 1993 | TE: | RLD: | No |
Complete Access Available with Subscription